# Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients

> **NCT03409692** · — · COMPLETED · sponsor: **Mario Boccadoro** · enrollment: 278 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DIAGNOSTIC_TEST:** Gene Expression Profiling

## Key facts

- **NCT ID:** NCT03409692
- **Lead sponsor:** Mario Boccadoro
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-14
- **Primary completion:** 2017-11-30
- **Final completion:** 2022-07-25
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2023-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03409692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03409692, "Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03409692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*